Patient Advocay in Rheumatology - A Patient Story

Keck School of Medicine of USC

C. Ames

Dermatologic Manifestations in Rheumatic Diseases

Saakshi Khattri

The Window of Opportunity: Blockbuster Drugs, Opioids in Rheumatolog…

RheumNow

J. Cush

PsA for the Dermatologist

Masterclasses in Dermatology

J. Merola, A. Gottlieb

Sex Matters: Gender Differences in PsA Outcomes & Management

RheumNow

L. Eder

High Level View of the Approach to Psoriatic Disease Treatment

Masterclasses in Dermatology

J. Merola

2022 GRAPPA Treatment Recommendations

GRAPPA - Group for Research and Assessment of Psoriasis and Psoriatic Arthritis

GRAPPA 2024 Debate- Managing MSK Symptoms in PsO Patients: Who Shoul…

GRAPPA - Group for Research and Assessment of Psoriasis and Psoriatic Arthritis

F. Proft

Diagnosing Psoriatic Arthritis for the Dermatologist: Making a Diffe…

Masterclasses in Dermatology

J. Merola, A. Gottlieb

ACR Convergence 2023 Highlights: Two Studies: TAK-279 (Tyk2) in PsA …

RheumNow

G. Valenzuela

Overview of Psoriasis: Clinical Presentation and Comorbidities in Ch…

National Psoriasis Foundation

A. Paller

Enthesitis & Dactylitis Management

RheumNow

A. Kavanaugh

Inflammatory Arthritis: What Is It?

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

Long COVID for the Rheumatologist

Cleveland Clinic Rheumatology

L. Calabrese

ACR Convergence 2023 Highlights: Myositis Pearls for Diagnosis and M…

Highlights from ACR Convergence 2023

L. Christopher-Stine

EULAR® 2024 Insights: Chronic Kidney Disease in Patients with Psoria…

EULAR® 2024 Insights

D. Gladman

EULAR® 2024 Insights: Reasons for Non-response to Treatments in Pati…

EULAR® 2024 Insights

F. Coşan

EULAR 2023 Insights: Is Methotrexate Safe for Men With an Immune-Med…

EULAR 2023 Insights

L. Fernando Perez-Garcia

Interdisciplinary Approaches to Psoriatic Disease: Combining Clinics…

Joseph Merola

A Year in Review: What Was New in Psoriasis Treatment in 2021 and Wh…

Joseph Merola